Kapral Shane Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
2
Insider Sells Sum
$165,459.96

Insider Activity of Kapral Shane

According to the SEC Form 4 filings, Kapral Shane, being in a position of

  1. Deputy Chief Financial Officer at TKO Group Holdings, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 1926 shares for $306,354,
    over all time since 2025-01-03, has bought 0 shares, and sold 1926 shares for $306,354.

Biography of Kapral Shane

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $306,3545100

Comparison of Insiders on Amount of Buys and Sells

2025-12-05PurchaseButterfly Network, Inc.
BFLY
200,000
0.0791%
$3.06$611,300+0.11%
2025-12-05PurchaseBiglari Holdings Inc.
BH
Chairman and CEO
1,465
0.0475%
$306.90$449,609-0.84%
2025-12-05SaleCytokinetics, Incorporated
CYTK
EVP, Chief Commercial Officer
52,486
0.0443%
$65.95$3.46M-0.42%
2025-12-05SaleDocuSign, Inc.
DOCU
director
363
0.0002%
$64.50$23,414+1.81%
2025-12-05SaleDominari Holdings Inc.
DOMH
COO
140,000
0.8589%
$3.82$534,254+1.94%
2025-12-05SaleDynatrace, Inc.
DT
director
253
<0.0001%
$44.24$11,193+0.47%
2025-12-05SaleDyne Therapeutics, Inc.
DYN
Chief Medical Officer
880
0.0006%
$20.72$18,234-2.12%
2025-12-05SaleDyne Therapeutics, Inc.
DYN
Chief Commercial Officer
144
0.0001%
$20.72$2,984-2.12%
2025-12-05SaleDyne Therapeutics, Inc.
DYN
CEO & President
2,662
0.0019%
$20.72$55,157-2.12%
2025-12-05SaleEnanta Pharmaceuticals, Inc.
ENTA
See Remarks
323
0.0015%
$14.23$4,596+2.6%
2025-12-05SaleEnanta Pharmaceuticals, Inc.
ENTA
See Remarks
542
0.0025%
$14.23$7,713+2.6%
2025-12-05SaleEnanta Pharmaceuticals, Inc.
ENTA
Chief Medical Officer
798
0.0036%
$14.23$11,356+2.6%
2025-12-05SaleEnanta Pharmaceuticals, Inc.
ENTA
Chief Product Strategy Officer
2,106
0.0096%
$14.23$29,968+2.6%
2025-12-05SaleEnanta Pharmaceuticals, Inc.
ENTA
Chief Business Officer
1,394
0.0064%
$14.23$19,837+2.6%
2025-12-05SaleEnanta Pharmaceuticals, Inc.
ENTA
Chief Scientific Officer
2,390
0.0109%
$14.23$34,010+2.6%
2025-12-05SaleEnanta Pharmaceuticals, Inc.
ENTA
President and CEO
4,743
0.0217%
$14.23$67,493+2.6%
2025-12-05SaleFennec Pharmaceuticals Inc.
FENC
director
10,000
0.0362%
$7.54$75,400+0.13%
2025-12-05SaleFive9, Inc.
FIVN
President
700
0.0009%
$20.53$14,371+0.58%
2025-12-05SaleFabrinet
FN
director
500
0.0014%
$482.11$241,057-0.76%
2025-12-05SaleIES Holdings, Inc.
IESC
Executive Chairman
3,774
0.0186%
$420.24$1.59M+1.99%
Total: 830495
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.